Correction to: Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy
Hongjie Huo, Yu Feng, Qiong Tang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBlood Coagulation and Thrombosis Mechanisms
Correction to: Cancer Chemotherapy and Pharmacology 10.1007/s00280-023-04630-8
In the original publication, the order of authors have been appeared incorrectly as
Feng Yu^1^ · Hongjie Huo^1^ · Qiong Tang^1^
The correct order should read as below:
Hongjie Huo^1^ · Yu Feng^1^ · Qiong Tang^1^
In addition, we have included funding note to the article as below:
This study was supported by Tianjin Union Medical Center (Grant number 2021YJ020).
The original article has been corrected.